Pay in 4 interest-free payments of $6.53 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Regulatory scrutiny on claims and ingredient sourcing remains a key challenge for suppliers and brands
Will there be future supply challenges for these medications
Therefore, while the Biden administrations proposed reinterpretation of Medicare Part D coverage of weight loss medications would allow for access to such therapies to approximately 3.4 million Medicare beneficiaries who have obesity, for budgetary reasons its unclear if the incoming Trump administration will go along with it
The trial is expected to conclude in late 2024
US$ 26.94
US$ 23.49
US$ 23.36
US$ 20.63
US$ 25.46
US$ 24.89
US$ 27.40
US$ 23.47
US$ 28.05
